Toward the antibody-catalyzed chemiluminescence. Design and synthesis of hapten

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 6, 1998, Pages 647-652

  Sawa, Masaaki ^a   Imaeda, Yasuhiro ^a   Hiratake, Jun ^a   Fujii, Ryota ^a   Umeshita, Ritsuko ^b   Watanabe, Mitsuo ^b   Kondo, Hitoshi ^b   Oda, Jun'ichi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNITIKA LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYTIC ANTIBODY; HAPTEN;

ANTIBODY COMBINING SITE; ARTICLE; CATALYSIS; CHEMOLUMINESCENCE; CONFORMATION; DECOMPOSITION; DRUG DESIGN; HYDROLYSIS;

ANTIBODIES, CATALYTIC; CHEMILUMINESCENT MEASUREMENTS; DRUG DESIGN; HAPTENS; HEMOCYANIN; HETEROCYCLIC COMPOUNDS; INDICATORS AND REAGENTS; MODELS, MOLECULAR; SERUM ALBUMIN, BOVINE;

EID: 0032539781     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00080-8     Document Type: Article

References (24)

1. 1. Pollack, S. J.; Jacobs, J. W.; Schultz, P. G. Science 1986, 234, 1570.
2. 2. Tramontano, A.; Janda, K. D.; Lerner, R. A. Science 1986, 234, 1566.
3. 3. Lerner, R. A.; Benkovic, S. J.; Schultz, P. G. Science 1991, 252, 659.
4. 4. Schultz, P. G.; Lerner, R. A. Science 1995, 269, 1835.
5. 5. (a) Reymond, J.-L.; Reber, J.-L.; Lerner, R. A. Angew. Chem. Int. Ed. Engl. 1994, 33, 475.
6. (b) Shevlin, C. G.; Hilton, S.; Janda, K. D. Bioorg. Med. Chem. Lett. 1994, 4, 297.
7. (c) Sinha, S. C.; Keinan, E. J. Am. Chem. Soc. 1995, 127, 3653.
8. 6. Beck, S.; Köster, H. Anal. Chem. 1990, 62, 2258.
9. 7. Bronstein, I.; Edwards, B.; Voyta, J. C. J. Biolumin. Chemilumin. 1989, 4, 99.
10. 8. Schaap, A. P.; Handley, R. S.; Giri, B. P. Tetrahedron Lett. 1987, 28, 935.
11. 9. Rongen, H. A. H.; Hoetelmans, R. M. W.; Bult, A.; Bennekom, W. P. V. J. Pharm. Biomed. Anal. 1994, 12, 433.
12. 10. (a) Nakatani, T.; Hiratake, J.; Shinzaki, A.; Umeshita, R.; Suzuki, T.; Nishioka, T.; Nakajima, H.; Oda, J. Tetrahedron Lett. 1993, 34, 4945.
13. (b) Nakatani, T.; Umeshita, R.; Hiratake, J.; Shinzaki, A.; Suzuki, T.; Nakajima, H.; Oda, J. Bioorg. Med. Chem. 1994, 2, 457.
14. 11. The Mopac 6.0 program was used for semiempirical calculations. The semiempirical optimizations were carried out using the PM3 method, (a) Stewart, J. J. P. J. Comput. Chem. 1989, 10, 209.
15. 12. Kozikowski, A. P.; Adamczyk, M. J. Org. Chem. 1983, 48, 366.
16. 13. Schaap, A. P. U.S. Patent 4 983 779, 1991; Chem. Abstr, 1991, 115, 49118b
17. 13. Schaap, A. P. U.S. Patent 4 983 779, 1991; Chem. Abstr, 1991, 115, 49118b
18. 14. McMurry, J. E. Chem. Rev. 1989, 89, 1513.
19. 15. Schaap, A. P.; Thayer, A. L.; Blossey, E. C; Neckers, D. C. J. Am. Chem. Soc. 1975, 97, 3741.
20. 6 : C, 68.86; H, 6.89; N, 3.09. Found : C, 68.78; H, 7.10; N, 2.89.
21. 17. Dennis, N.; Katritzky, A. R.; Matsuo, T.; Parton, S. K.; Takeuchi, Y. J. Chem. Soc., Perkin Trans. I 1974, 746.
22. 18. Jung, M. E. J. Org. Chem. 1992, 57, 3528.
23. 19. Dailey, O. D., Jr. J. Org. Chem. 1987, 52, 1984.
24. + : 513.3077. Found: 513.3083.